Physician profile
Abdullah Ali
NPI 1255845053
$11,279.34
in general payments reported to CMS, 2019-2025
38 companies · $1,639 in 2025
The $1,639 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $238 · 2021: $2,641 · 2022: $2,212 · 2023: $1,312 · 2024: $2,453 · 2025: $1,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,837 · Travel and Lodging: $1,240 · Education: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,837.26 |
| Travel and Lodging | $1,240.11 |
| Education | $326.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,085.16 | 2021-2024 | Bulkamid, Axonics |
| Janssen Biotech, INC. | $1,410.40 | 2019-2025 | Erleada, Akeega, Balversa |
| Procept Biorobotics Corporation | $1,349.71 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $875.50 | 2020-2023 | |
| Endo Pharmaceuticals INC. | $618.40 | 2019-2024 | Xiaflex, Aveed, Edex |
| Myovant Sciences INC. | $500.32 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $446.67 | 2024-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $420.52 | 2023-2025 | Prolaris, Myrisk |
| Coloplast Corp | $375.92 | 2021-2025 | |
| Pfizer INC. | $354.20 | 2020-2025 | |
| Medtronic, INC. | $320.95 | 2023 | Interstim |
| Aytu Biopharma, INC. | $276.20 | 2019-2020 | |
| Urovant Sciences INC | $250.00 | 2021-2022 | |
| Abbvie INC. | $207.02 | 2019-2025 | Botox |
| Teleflex LLC | $177.64 | 2021-2025 | Urolift |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $177.39 | 2023-2025 | Eligard, Jatenzo |
| Clarus Therapeutics INC. | $147.60 | 2021 | |
| Allergan, INC. | $144.15 | 2021 | |
| Progenics Pharmaceuticals, INC. | $136.91 | 2023-2025 | Pylarify |
| Blue Earth Diagnostics | $128.79 | 2021-2024 | |
| Dentsply Ih Ab | $108.51 | 2021-2025 | Lofric, Lofric |
| Antares Pharma, INC. | $105.98 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $99.32 | 2021-2022 | |
| Therapeuticsmd, INC. | $91.49 | 2019 | |
| Alnylam Pharmaceuticals INC. | $69.32 | 2022-2024 | Givlaari |
| Verity Pharmaceuticals INC. | $47.40 | 2024-2025 | Trelstar |
| Boston Scientific Corporation | $46.03 | 2025 | Bulkamid, Axonics |
| Novo Nordisk INC | $42.99 | 2024 | Rivfloza |
| Ferring Pharmaceuticals INC. | $40.73 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $33.38 | 2022-2024 | |
| Photocure INC | $30.73 | 2020-2022 | |
| Neotract INC. | $29.27 | 2019 | |
| Agiliti Surgical, INC. | $27.07 | 2025 | Ge Healthcare Bkfusion Prostate Biopsy, Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Halozyme INC | $22.20 | 2023 | |
| Calyxo, INC. | $21.01 | 2025 | Cvac Aspiration System |
| Endo USA, INC. | $20.94 | 2024 | Xiaflex |
| Kyowa Kirin, INC. | $20.59 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.